Loading Events

« All Events

  • This event has passed.

Advances in Prostate Imaging and Ablative Treatment of Prostate Cancer – NYU Langone Medical Center

June 17, 2016 - June 18, 2016


The primary goal of this conference is to provide the urologist and radiologist with a comprehensive review of advances in prostate imaging, biopsy, assessment of prostate cancer aggressiveness, and minimally invasive ablative therapy (MIAT) of prostate cancer. The course will be organized into sessions focusing on prostate imaging, prostate biopsy, disease risk stratification and MIAT. The information will be disseminated via lectures, case discussions, and panel discussions. The educational focus is designed to optimize selection of candidates and delivery of MIAT for prostate cancer by identifying the ideal biopsy strategy in order to reliably assess the extent and biological aggressiveness of the disease; to discuss novel tumor markers for improving risk stratification; to apply the latest advances in imaging of prostate cancer in order to improve better assessment of the site and extent of clinically significant disease and enable target biopsies, and critically examine the most promising approaches for ablating prostate cancer and presenting technological pearls to maximize outcomes following minimally invasive ablative treatment of prostate cancer.

Educational Objectives

At the conclusion of this activity, clinicians should be able to:
  • Evaluate the merits of 12 core random biopsy vs MRI-guided in bore biopsy vs 3D co-registration of MRI and TRUS techniques to optimize assessing site and risk stratification of prostate cancer
  • Use mpMRI to identify cases were prostate biopsy can be safely omitted
  • Describe the sequences obtained during a prostatic mpMRI, including contrast enhancement, and diffusion weighted imaging
  • Assess the optimal timing for performing mpMRI post-biopsy or post-ablation
  • Describe the ablative properties of HIFU, cryotherapy, laser, radio-frequency and VPT, differentiate between focal, hemi-ablation and subtotal gland ablation
  • Select the most appropriate minimally invasive ablative therapy for management of patients’ with localized prostate cancer
  • Evaluate and differentiate between different approaches for using MRI to guide prostate biopsy
  • Discuss factors that enhance the effectiveness of minimally invasive procedures and establish and utilize treatment strategies that decrease complications.
  • Utilize various tools that are commercially available for assessing the molecular signature of prostate cancers

Target Audience

Practicing and academic urologists and radiologists.


June 17, 2016
June 18, 2016
Event Categories:
, , , , , ,


NYU Langone Medical Center
+1 212-263-5295


CPD Credits
Conference size


NYU Langone Medical Center
550 First Avenue
New York, NY 10016 United States
+ Google Map
+1 646-929-7870

Search Hotels

Check-in date
Check-out date